Erlotinib in Combination With Temozolomide in Treating Relapsed/Recurrent/Refractory Pediatric Solid Tumors

Clinical trial NCT02689336 · WITHDRAWN

Trial details

NCT number: NCT02689336
Sponsor: Washington University School of Medicine
Status: WITHDRAWN
Phase: Phase 2
Study type: INTERVENTIONAL

Glioma Rhabdomyosarcoma Osteosarcoma Medulloblastoma Neuroectodermal Tumor Ependymoma Ewing's Sarcoma Wilms Tumor

Start date: 2016-08-06
Primary completion: 2019-11-30
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.